Eleonora Ghisoni

PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function

Matteo Morotti, Alizée J Grimm, Helen Carrasco Hope et al. · Nature · 2024 · 197 citations · Full text

Life Sciences, Immunology, Oncology +17

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 186 citations · Full text

Life Sciences, Immunology, Oncology +16

Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING

Marine Bruand, David Barras, Marco Mina et al. · Cell Reports · 2021 · 138 citations · Full text

Medicine, Immunology, Oncology +17

Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 ⁺ T-myeloid cell networks in melanoma

David Barras, Eleonora Ghisoni, Johanna Chiffelle et al. · Science Immunology · 2024 · 91 citations · Full text

Medicine, Immunology, Oncology +11

Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma

Johanna Chiffelle, David Barras, Rémy Pétremand et al. · Immunity · 2024 · 43 citations

Life Sciences, Immunology, Oncology +16